Showing results (51-60 of 326) with videos related to

Sort By:
Pageof 33
CNS Drug Reviews|February 22, 2003
Moclobemide: therapeutic use and clinical studiesUdo Bonnet
Fortschritte Der Neurologie-Psychiatrie|November 12, 2025
[Cannabinoid Hyperemesis Syndrome: A Scoping Review]Udo Bonnet
Clinical Neuropharmacology|April 13, 2026
Venlafaxine Is of Variable Effectiveness in Severe Major Depression, Depending on Patient Treatment Response ExpectationUdo Bonnet
Clinical Neuropharmacology|January 13, 2016
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis EnigmaUdo Bonnet
Life Sciences|November 13, 2016
How much alcohol is in ketamine's antidepressant action?Udo Bonnet
Der Nervenarzt|July 21, 2025
[The cannabinoid hyperemesis syndrome-A narrative review]Udo Bonnet
Frontiers in Psychiatry|August 1, 2020
Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification TreatmentMichael Specka, Thomas Kuhlmann, Jürgen Sawazki, et al.
Medical Hypotheses|August 25, 2019
The sour side of vitamin C might mediate neuroprotective, anticonvulsive and antidepressant-like effectsUdo Bonnet
Fortschritte Der Neurologie-Psychiatrie|January 28, 2026
Cannabis hyperemesis syndrome: the rare case of a valid diagnosis plus hypersensitization hypothesis for development and chronification of this severe somatic cannabis use disorderUdo Bonnet
Frontiers in Psychiatry|May 10, 2021
Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification TreatmentMichael Specka, Thomas Kuhlmann, Jürgen Sawazki, et al.
Pageof 33